Are side effects of xtandi worse than darolutamide

April 5, 2026Written by Navis AI

Comparing Xtandi vs Darolutamide Side Effects

Great question—this is something many patients with prostate cancer consider when discussing treatment options with their oncologist. Let me break down what we know about these two medications.

What These Drugs Are

Both Xtandi (enzalutamide) and darolutamide are androgen receptor inhibitors—they work by blocking male hormones that fuel prostate cancer growth. They're used for castration-resistant prostate cancer (CRPC) and metastatic hormone-sensitive prostate cancer (mHSPC).

Tell us what’s going on with your cancer. 2 free answers, then a free account.

Side Effect Profiles: What the Data Shows

XTANDI (Enzalutamide) commonly reported side effects:

  • Fatigue (30-40% of patients)
  • Hot flashes (20-30%)
  • Diarrhea (20-25%)
  • Hypertension/high blood pressure (15-20%)
  • Seizures (rare, <1%, but important to monitor)
  • Cognitive effects ("chemo brain")

DAROLUTAMIDE commonly reported side effects:

  • Fatigue (20-25%)
  • Hot flashes (15-20%)
  • Diarrhea (15-18%)
  • Rash (10-15%)
  • Generally considered to have a slightly milder side effect profile

The Clinical Reality

According to NCCN Guidelines for Prostate Cancer, both drugs are considered standard options, and the choice often depends on:

  • Your individual tolerance and medical history
  • Other medications you're taking
  • Specific side effects that concern you most
  • Your PSA response and disease progression

Key point: Studies like the ARAMIS trial (darolutamide) and AFFIRM trial (enzalutamide) show both are effective, but individual responses vary significantly. What causes severe side effects in one patient may be minimal in another.

Questions to Ask Your Oncologist

  1. "Based on my specific health situation, which drug do you recommend and why?"
  2. "What side effects should I watch for, and when should I contact you?"
  3. "Are there any drug interactions with my current medications?"
  4. "If I experience significant side effects, can we switch to the other medication?"
  5. "How will we monitor my response to treatment?"

Important Context

The "better" drug isn't about which has fewer side effects overall—it's about which is better for your specific case. Your oncologist will consider your PSA levels, metastatic disease pattern, kidney/liver function, and other factors when recommending one over the other.

According to the American Cancer Society, both medications have demonstrated survival benefits in advanced prostate cancer, so either could be appropriate depending on your individual circumstances.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your next question, already answered

Tap to keep going. 2 free answers, then a free account.

Ask Navis about your case

That answer is general. Ask about your specific situation. Answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

  • Built by OpenCancer’s team of physician-scientists and cancer survivors.
  • Last updated April 5, 2026. Informational only — not a substitute for your oncology team.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

More questions about General